A new kind of pain medication has been approved for sale by the Food and Drug Administration. It is being touted as an alternative to opioids. It works differently, and it is not addictive.

The success of suzetrigine supports the goal of moving beyond relieving pain to doing so safely, without perpetuating cycles ...

A new kind of pain medication has been approved for sale by the Food and Drug Administration. It is being touted as an alternative to opioids. It works differently, and it is not addictive.

(CNN) — The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a prescription pill that ...

Editor’s Note (1/31/25): The U.S. Food and Drug Administration has approved the novel nonopioid medication suzetrigine for acute pain. That pain ranges from moderate to severe. The drug was ...

Broadfoot: So this new pain drug is being made by Vertex Pharmaceuticals. It was called VX-548 for quite some time while it was under development. Now they’re calling it suzetrigine.

“Unfortunately, that drug seems to only work for acute, post-surgical pain. It has yet to show success for chronic pain.” The new molecule addresses pain through a different approach: Instead of ...

A research team funded by the National Institutes of Health (NIH) has developed a medication that shows promise in treating acute and chronic pain. The drug, known as VIP36, targets the body's ...

These mice lack a gene called SPARC, causing early spinal deterioration, inflammation, and chronic pain. Researchers administered two drugs to these mice: o-vanillin, a natural compound extracted ...

Peripheral neuropathy can cause nerve pain, tingling, numbness, burning, ... Prescription medications. According to the National Institute of Neurological Disorders and Stroke, ...

Early clinical trial results suggest that a groundbreaking new antibiotic drug could be a “massive game changer” for some patients suffering from chronic lower back pain.

These observations underline that the treatment of neuropathic pain is still an unmet medical need. New approaches to the pharmacotherapy of neuropathy embrace different lines of work, including a ...